Skip to content

Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes

BHIVA: Concerns over confidentiality, drug interactions, communication, barriers to integrating GPs into HIV care

Unexpected drug interaction found between Kaletra and rosuvastatin

CROI: TDM-based PI dose escalation shows modest benefit in black and Hispanic, but not Caucasian, treatment-experienced patients

Kaletra monotherapy studies yield conflicting results

Etravirine (TMC125, Intelence) granted accelerated approval in US

Interaction between efavirenz and phenytoin can result in undetectable blood levels of efavirenz

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment

Failure to suppress viral load more likely with nevirapine than efavirenz if ART started during TB treatment